Department of Nephrology, Chongqing Ninth People' Hospital, Chongqing, China.
Department of Nephrology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ther Apher Dial. 2022 Aug;26(4):756-768. doi: 10.1111/1744-9987.13755. Epub 2021 Dec 4.
Medium cut-off (MCO) dialyzers were designed to provide better clearance of uremic toxins. We conducted a meta-analysis comparing MCO with high-flux (HF) dialyzers for the effect on uremic toxins in maintenance hemodialysis (HD) patients. Five databases were systematically searched for relevant studies and nine studies were identified finally. Reduction ratio (RR) of urea, urea, creatinine, β2-macroglobulin (β2-MG), kappa free light chain (κFLC), and lambda FLC (λFLC) levels were not significantly different between MCO and HF dialyzers. But RR of β2-MG, κFLC, and λFLC were greater for MCO than HF dialyzers. MCO dialyzers could better reduce tumor necrosis factor-α (TNF-α) levels. Subgroup analysis stratified by study design indicated that in randomized controlled trial (RCT) studies, albumin levels was lower in MCO than HF dialyzers group, but the two dialyzers treatments were equivalent in non-RCT subgroup. Compared with HF dialyzers, MCO dialyzers provided higher middle-molecules uremic toxins clearance and obviously reduced TNF-α levels.
中分子截留(MCO)透析器旨在提供更好的尿毒症毒素清除效果。我们进行了一项荟萃分析,比较了 MCO 与高通量(HF)透析器对维持性血液透析(HD)患者尿毒症毒素的影响。系统地在五个数据库中搜索了相关研究,最终确定了九项研究。MCO 和 HF 透析器之间尿素、肌酐、β2-微球蛋白(β2-MG)、κ 轻链(κFLC)和 λ 轻链(λFLC)水平的降低率(RR)没有显著差异。但是,MCO 透析器的β2-MG、κFLC 和 λFLC 的 RR 大于 HF 透析器。MCO 透析器可以更好地降低肿瘤坏死因子-α(TNF-α)水平。按研究设计分层的亚组分析表明,在随机对照试验(RCT)研究中,MCO 组的白蛋白水平低于 HF 透析器组,但在非 RCT 亚组中,两种透析器治疗效果相当。与 HF 透析器相比,MCO 透析器提供了更高的中分子尿毒症毒素清除率,明显降低了 TNF-α 水平。